The European Medicines Agency has decided to take its second chance to argue that Brexit is a frustrating event in its property dispute with Canary Wharf Group and lodged its appeal against
February’s High Court ruling. The agency was
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE.
Register
Find Out More